Generic growth strategies manufacturers

449 views

Published on

Aarkstore.com 15% Discount || Generic Growth Strategies - Manufacturers to Increase Focus ||

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
449
On SlideShare
0
From Embeds
0
Number of Embeds
3
Actions
Shares
0
Downloads
8
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Generic growth strategies manufacturers

  1. 1. Aarkstore.com announces, The Latest market research report is available inits vast collection:Generic Growth Strategies - Manufacturers to Increase Focuson Super Generics and Biosimilars to Drive Revenueshttp://www.aarkstore.com/reports/Generic-Growth-Strategies-Manufacturers-to-Increase-Focus-on-Super-Generics-and-Biosimilars-to-Drive-Revenues-128803.htmlCompany has released its research “Generic Growth Strategies - Manufacturers toIncrease Focus on Super Generics and Biosimilars to Drive Revenues”. It provides acomprehensive overview of the generic drugs market, analysis of upcomingnoteworthy patent expirations, and trends and issues facing the generics market.The report delves into much detail on the current landscape; changes that havestructured the generic drugs market in the last 30 years; and the reason behind theplayers’ urgency in developing and implementing generic growth strategies. Thereport also contains impact analysis of the regulatory landscape in the majorgeographies pertaining to the generic drugs market. Major strategies adopted by theleading companies in the generic drugs market have been analyzed in much detail,along with an elaborate company portfolio and strategic analysis of leading genericplayers.ScopeThe scope of this report includes -- Detailed study of generic growth strategies with special emphasis on strategieswhich help in combating intensive competition.- Analysis of the major strategies adopted by companies looking to expandgeographical reach.- Case studies of successful generic growth strategies.
  2. 2. - Competitive profiling of leading companies. The key companies studied in thisreport are Teva, Sandoz, Hospira, Watson, Mylan, Perrigo, STADA, DRL, Par, Apotexand Actavis.Table of contents:1.1 List of Tables 51.2 List of Figures 52 Generic Growth Strategies: Introduction 62.1 Company Report Guidance 73 Generic Growth Strategies: Market Overview 83.1 Overview of the Generics Market 83.2 Patent Expiries – Peak Years 83.3 Patent Expiration of Blockbuster Drugs, By Therapeutic Area 103.4 Upcoming Patent Expiries 113.5 Trends and Issues 113.5.1 ANDA Filings and Approvals are on the Rise 113.5.2 European Market for Small Molecule Generic Drugs versus Biosimilars 133.5.3 Untapped Generics Market in Certain European Countries 143.5.4 Biosimilars Focus – Innovators as Well as Generics Companies 153.5.5 Drop in Patent Applications by Top Innovator Companies a Cause of Worry forGenerics 163.5.6 Evergreening Strategies Pose an Issue 173.5.7 Market Forces in the European Union 174 Generic Growth Strategies: Current Generic Landscape 194.1 Generic Industry Structure 194.2 Generic Drug Industry Evolution – Changes in the Last 30 Years 204.2.1 Stronger Patent Protection 204.2.2 Need to Differentiate is Important for Generics Now More Than Ever 204.2.3 Hatch-Waxman Act and ANDA 214.3 Challenges Facing Generics Industry 234.3.1 LCM Strategy Adopted by Innovators to Stay Competitive Poses Challenge toGenerics 234.3.2 R&D Productivity at a Low for Innovator Companies – Likely to Affect Genericsin the Long Run 244.4 Reasons to Implement Generic Growth Strategies 26
  3. 3. List of FiguresList of Tables are also include.For more DISCOUNT related Reports Plz follow The link:Cardiac Rhythm Management Devices Market to 2017 - Technological Innovations,Regulatory Approvals and Increasing Disease Prevalence Present GrowthOpportunitiesCardiac Assist Device Market to 2017 – Increasing Uptake of Ventricular AssistDevices and Total Artificial Heart to Drive GrowthGeneric Growth Strategies - Manufacturers to Increase Focus on Super Generics andBiosimilars to Drive RevenuesRx-to-OTC Switching Strategies - New Switching Opportunities in WeightManagement and Smoking Cessation, but Encouraging the Uptake of Self-MedicationRemains a ChallengeAntifungals Market to 2017 - Generic Erosion of Major Polyenes, Azoles, Allylaminesand Echinocandins to Slow Value GrowthSearch More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain
  4. 4. Innovation with Low Risk and High Value OfferingsGeneric Growth Strategies - Manufacturers to Increase Focus on Super Generics andBiosimilars to Drive RevenuesRx-to-OTC Switching Strategies - New Switching Opportunities in WeightManagement and Smoking Cessation, but Encouraging the Uptake of Self-MedicationRemains a ChallengeAntifungals Market to 2017 - Generic Erosion of Major Polyenes, Azoles,Allylamines and Echinocandins to Slow Value GrowthYou can also request for sample page of above mention reports onsample@aarkstore.comFor More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: enquiry@aarkstore.com

×